As we learn more about how the Zika virus is transmitted, health-care providers need clear guidance to inform discussions with their patients about possible exposure to Zika virus and how to prevent its transmission to developing fetuses and sexual partners. During this COCA Webinar, clinicians will learn about the updated CDC interim guidance for caring for reproductive age women and men with possible Zika exposure, CDC interim guidance for prevention of sexual transmission of Zika, preventing transmission of Zika virus in labor and delivery settings, interpreting pediatric testing guidance, and the US Zika pregnancy registry.
Join by Phone:
888-769-8519 (U.S. Callers)
1-517-308-9276 (International Callers)
Passcode: 1002827
Join by Webinar: https://www.mymeetings.com/nc/join.php?i=PW7730540&p=1002827&t=c
• Describe current CDC guidance for clinicians caring for women and men of reproductive age with possible Zika exposure
• Explain the purpose and scope of the US Zika Pregnancy Registry and clinicians' role in ensuring its success
• Interpret pediatric testing guidance in newborns and infants with possible Zika virus infection.Christine K. Olson, MD, MPH
Medical Officer
Division of Reproductive Health
National Center for Chronic Disease Prevention and Health Promotion
Centers for Disease Control and Prevention
Jefferson M. Jones, MD, MPH
EIS Officer
Division Of Scientific Education And Professional Development
Center For Surveillance, Epidemiology And Laboratory Services
Centers for Disease Control and Prevention
John T. Brooks, MD
Senior Medical Advisor
Division of HIV/AIDS Prevention
National Center for HIV/AIDS, Viral Hepatitis, STD, and TB Prevention
Centers for Disease Control and Prevention
CME: The Centers for Disease Control and Prevention is accredited by the Accreditation Council for Continuing Medical Education (ACCME®) to provide continuing medical education for physicians.
The Centers for Disease Control and Prevention designates this live activity for a maximum of 1.0 AMA PRA Category 1 Credit™. Physicians should only claim credit commensurate with the extent of their participation in the activity.
CNE:The Centers for Disease Control and Prevention is accredited as a provider of Continuing Nursing Education by the American Nurses Credentialing Center's Commission on Accreditation.
This activity provides 1.0 contact hour.
IACET CEU: The Centers for Disease Control and Prevention is authorized by IACET to offer 1.0 CEU's for this program.
CECH: Sponsored by the Centers for Disease Control and Prevention, a designated provider of continuing education contact hours (CECH) in health education by the National Commission for Health Education Credentialing, Inc. This program is designed for Certified Health Education Specialists (CHES) and/or Master Certified Health Education Specialists (MCHES) to receive up to 1.0 total Category I continuing education contact hours. Maximum advanced level continuing education contact hours available are 0. CDC provider number 98614.
CPE: The Centers for Disease Control and Prevention is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education. This program is a designated event for pharmacists to receive 1.0 CEUs in pharmacy education. The Universal Activity Number is 0387-0000-16-111-L04-P and enduring 0387-0000-16-111-H04-P course category.
This activity is knowledge based.
AAVSB/RACE: This program was reviewed and approved by the AAVSB RACE program for 1.0 hours of continuing education in the jurisdictions which recognize AAVSB RACE approval. Please contact the AAVSB RACE Program at race@aavsb.org if you have any comments/concerns regarding this program’s validity or relevancy to the veterinary profession.
CPH: The Centers for Disease Control and Prevention is a pre-approved provider of Certified in Public Health (CPH) recertification credits and is authorized to offer 1 CPH recertification credit for this program.